FAS and chronic obstructive pulmonary disease: Other studies investigating apoptosis-related factors in COPD have shown that plasma levels of soluble Fas, an inhibitor of apoptosis, are only increased in patients with severe COPD, while plasma levels of the inducer of apoptosis, sFasL, appear unchanged with disease severity [11,12].